These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37140357)

  • 61. Effect of riluzole on MK-801 and amphetamine-induced hyperlocomotion.
    Lourenço Da Silva A; Hoffmann A; Dietrich MO; Dall'Igna OP; Souza DO; Lara DR
    Neuropsychobiology; 2003; 48(1):27-30. PubMed ID: 12886037
    [TBL] [Abstract][Full Text] [Related]  

  • 62. WITHDRAWN: Tacrine for Alzheimer's disease.
    Qizilbash N; Birks J; Lopez Arrieta J; Lewington S; Szeto S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD000202. PubMed ID: 17636619
    [TBL] [Abstract][Full Text] [Related]  

  • 63. NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
    Daviglus ML; Bell CC; Berrettini W; Bowen PE; Connolly ES; Cox NJ; Dunbar-Jacob JM; Granieri EC; Hunt G; McGarry K; Patel D; Potosky AL; Sanders-Bush E; Silberberg D; Trevisan M
    NIH Consens State Sci Statements; 2010 Apr; 27(4):1-30. PubMed ID: 20445638
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: results of a meta-analysis.
    Farlow MR; Small GW; Quarg P; Krause A
    Dement Geriatr Cogn Disord; 2005; 20(2-3):192-7. PubMed ID: 16088144
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer's Disease.
    Reed C; Happich M; Raskin J; Tockhorn-Heidenreich A; Belger M
    J Prev Alzheimers Dis; 2019; 6(2):90-99. PubMed ID: 30756115
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
    Tanović A; Alfaro V
    Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity.
    Sozio P; D'Aurizio E; Iannitelli A; Cataldi A; Zara S; Cantalamessa F; Nasuti C; Di Stefano A
    Arch Pharm (Weinheim); 2010 Mar; 343(3):133-42. PubMed ID: 20186865
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ameliorative effect of nicergoline on cognitive function through the PI3K/AKT signaling pathway in mouse models of Alzheimer's disease.
    Zang G; Fang L; Chen L; Wang C
    Mol Med Rep; 2018 May; 17(5):7293-7300. PubMed ID: 29568940
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Potential predictors of hippocampal atrophy in Alzheimer's disease.
    Dhikav V; Anand K
    Drugs Aging; 2011 Jan; 28(1):1-11. PubMed ID: 21174483
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The neuroprotective drug riluzole acts via small conductance Ca2+-activated K+ channels to ameliorate defects in spinal muscular atrophy models.
    Dimitriadi M; Kye MJ; Kalloo G; Yersak JM; Sahin M; Hart AC
    J Neurosci; 2013 Apr; 33(15):6557-62. PubMed ID: 23575853
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons.
    Centonze D; Calabresi P; Pisani A; Marinelli S; Marfia GA; Bernardi G
    Neuropharmacology; 1998 Aug; 37(8):1063-70. PubMed ID: 9833635
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis.
    Albertini C; Salerno A; Atzeni S; Uliassi E; Massenzio F; Maruca A; Rocca R; Mecava M; Silva FSG; Mena D; Valente P; Duarte AI; Chavarria D; Bissaro M; Moro S; Federico S; Spalluto G; Soukup O; Borges F; Alcaro S; Monti B; Oliveira PJ; Menéndez JC; Bolognesi ML
    ACS Chem Neurosci; 2022 Aug; 13(15):2252-2260. PubMed ID: 35868251
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
    Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
    Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
    Lipton SA
    Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Riluzole for the treatment of amyotrophic lateral sclerosis.
    Saitoh Y; Takahashi Y
    Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D.
    Annweiler C; Beauchet O
    Drugs Aging; 2012 Feb; 29(2):81-91. PubMed ID: 22233455
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The fraction of activated N-methyl-D-aspartate receptors during synaptic transmission remains constant in the presence of the glutamate release inhibitor riluzole.
    Rammes G; Zieglgänsberger W; Parsons CG
    J Neural Transm (Vienna); 2008 Aug; 115(8):1119-26. PubMed ID: 18493706
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effects of minocycline or riluzole treatment on spinal root avulsion-induced pain in adult rats.
    Chew DJ; Carlstedt T; Shortland PJ
    J Pain; 2014 Jun; 15(6):664-75. PubMed ID: 24667712
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer's disease.
    Francis PT
    Neurodegener Dis; 2008; 5(3-4):241-3. PubMed ID: 18322401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.